Kapitalo Investimentos Ltda Incyte Corp Transaction History

Kapitalo Investimentos Ltda

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 29, 2024	SELL	$52.16 - $64.19 $200,346 - $246,553	-3,841 Reduced 42.87%	5,119 $321 Million
Q3 2023 Mar 29, 2024	BUY	$57.77 - $65.93 $458,000 - $522,693	7,928 Added 768.22%	8,960 $518 Million
Q2 2023 Mar 29, 2024	SELL	$60.95 - $75.51 $42,543 - $52,705	-698 Reduced 40.35%	1,032 $64.2 Million
Q1 2023 Mar 29, 2024	BUY	$70.23 - $86.01 $121,497 - $148,797	1,730 New	1,730 $125 Million

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

Stay updated on Kapitalo Investimentos Ltda with notifications on news.